UPC Stock: Universe Pharmaceuticals Inc. Stock Price, Analysis & Insights
Get live upc stock price $5.62, comprehensive Universe Pharmaceuticals Inc. stock analysis, charts, news, and expert forecast. Real-time upc stock data and investment insights.
Loading chart...
Company Overview
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
Company Information
- CEO
- Gang Lai
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 225
Contact Information
- Address
- No. 265, Jingjiu Avenue
- Country
- CN
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 1.52)
Business Model & Strategy
Universe Pharmaceuticals Inc. operates in the Drug Manufacturers - Specialty & Generic industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Gang Lai, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Drug Manufacturers - Specialty & Generic model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Universe Pharmaceuticals Inc. competes in the Drug Manufacturers - Specialty & Generic within the broader Healthcare. With 3.2 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Market, Universe Pharmaceuticals Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Universe Pharmaceuticals Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Universe Pharmaceuticals Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Universe Pharmaceuticals Inc.
- ⚠Investors should consider how Universe Pharmaceuticals Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
3.17M
P/E Ratio
-0.02
Beta
1.52
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 3.17M market capitalization
- Trading Volume: 3.37M shares traded today
- Price Range: 52-week range of $2.51 - $27.16
- Exchange: Listed on NASDAQ Global Market
Financial Metrics
Market Analysis for Universe Pharmaceuticals Inc.
Universe Pharmaceuticals Inc. (UPC) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. With a current market capitalization of 3.17M, the company represents a significant player in its market. The stock is currently trading at $5.62 with a positivedaily change of 31.16%.
The company's 225 employee base and presence on the NASDAQ Global Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.02, beta of 1.52, and 52-week price range from $2.51 to $27.16when evaluating investment opportunities.
Why Invest in Universe Pharmaceuticals Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Market)
- • Experienced leadership under Gang Lai
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.